Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases - Lifestyle

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

May 31, 2026

Press Releases - Lifestyle

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

May 31, 2026

Press Releases - Lifestyle

Guerra Wealth Advisors Invites South Florida Community to Join the St. Jude Walk Miami as a Champion Sponsor

May 30, 2026

Press Releases - Lifestyle

NUAI Deadline: NUAI Investors with Losses in Excess of $100K Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit

May 30, 2026

Press Releases - Lifestyle

SES AI Corporation Deadline: SES Investors with Losses in Excess of $100K Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm

May 30, 2026

Press Releases - Lifestyle

STLA Deadline: STLA Investors with Losses in Excess of $100K Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit

May 30, 2026

Press Releases - Lifestyle

Alley Cat Allies Continues to Protect the Cats of the Paseo del Morro and Collaborates with Puerto Rico Leaders

May 30, 2026

Press Releases - Lifestyle

Ducks Unlimited Completes Historic $4.06 Billion Campaign

May 30, 2026

Press Releases - Lifestyle

Cupshe Returns to Miami Swim Week 2026 With “The Arrival” at Temple House

May 30, 2026

Press Releases - Lifestyle

GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

May 30, 2026

Page 1432 of 4228 Prev 1 … 1,431 1,432 1,433 … 4,228 Next

No Result

View All Result

Home

Cision PR Newswire

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

Guerra Wealth Advisors Invites South Florida Community to Join the St. Jude Walk Miami as a Champion Sponsor

NUAI Deadline: NUAI Investors with Losses in Excess of $100K Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit

SES AI Corporation Deadline: SES Investors with Losses in Excess of $100K Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm

STLA Deadline: STLA Investors with Losses in Excess of $100K Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit

Alley Cat Allies Continues to Protect the Cats of the Paseo del Morro and Collaborates with Puerto Rico Leaders

Ducks Unlimited Completes Historic $4.06 Billion Campaign

Cupshe Returns to Miami Swim Week 2026 With “The Arrival” at Temple House

GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

Recommended

Innoscience’s current products are not affected by both rulings of the Munich Regional Court

Synergetics.ai Announces Broad Support for Emerging Agentic AI and Agent Payment Standards

Popular News

The Wealth Company Launches Gift City Fund to Give NRIs a Single, Dollar-Denominated Route into India’s Mutual Fund Market

Microvast Holdings, Inc. (MVST) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Trucking Industry Crowns 2026 National Truck Driving Champion

FRONTERA ANNOUNCES SECOND QUARTER 2026 RESULTS

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands